Open

This study tests whether RL-007 improves cognitive impairment associated with schizophrenia

This study tests whether the investigational product RL-007 improves cognitive impairment associated with schizophrenia

Age & Gender

18 years ~ 55 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Extended hours (M-F, early morning or evening)
Visits can be combined with regular clinical appointments

Location

North Carolina (Durham, Orange, Wake)

What will be asked of you

At each visit, you will meet with a member of the study team to complete interviews and questionnaires. The study will also involve vital signs, blood draws, EKGs, and collecting urine samples. Participants must be willing to take the provided study medication everyday.

Incentives

Participants will be compensated at the end of each study visit, Visa giftcard., gas reimbursement

In-person visits:
4

Phone or online visits:
5

Total length of participation:
8 weeks

Looking for Specific Volunteers

Able to participate:

Have a diagnosis of schizophrenia
Outpatient, with no hospitalization for worsening of schizophrenia within 3 months prior to screening
Be on stable antipsychotic treatment, except for clozapine

Not eligible if:

Prior exposure to RL-007
Current diagnosis of another major psychiatric disorder, intellectual disability, or any major neurological disease, brain injury, epilepsy, or severe brain trauma.
Known sensitivity to any of the planned study interventions, or components thereof, or drug or other allergy
Has undergone electroconvulsive therapy within the past 12 months

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Medical School Wing B (UNC-Chapel Hill)
332 Emergency Room Dr, Chapel Hill, NC 27514, USA

Secondary Visit Location

North Carolina Psychiatric Research Center
401 East Whitaker Mill Road, Raleigh, NC, USA

Additional Study Information

Principal Investigator

Fred Jarskog
Psychiatry - General

Study Type

Clinical or Medical
Interventional

Study Topics

Chronic Conditions
Mental and Emotional Health

IRB Number

23-0399

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.